Self-monitoring of blood glucose in diabetes mellitus: Arguments for an individualized approach;Blutzuckerselbstkontrolle bei diabetes mellitus: Plädoyer für ein individuelles selbstkontrollkonzept

Deutsches Arzteblatt

Volumn 106, Issue 37, 2009, Pages 587-594

  Nauck, Michael A ^a   El Ouaghlidi, Andrea ^b   Vardarli, Irfan ^a  

^a DIABETESZENTRUM BAD LAUTERBERG   (Germany)

^b Gastroenterologie Hepatologie Diabetologie und Stoffwechsel   (Germany)

Author keywords

Blood sugar measurement; Clinical research; Diabetes mellitus; Self monitoring; Treatment

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; LIRAGLUTIDE; LONG ACTING INSULIN; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA;

BEDTIME DOSAGE; CLINICAL FEATURE; CONTROL; DIABETES MELLITUS; DIET THERAPY; DRUG DOSE TITRATION; EVIDENCE BASED PRACTICE; GLUCOSE BLOOD LEVEL; HEALTH CARE ORGANIZATION; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MEASUREMENT; METABOLIC REGULATION; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SELF MONITORING; TREATMENT PLANNING;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; SELF ADMINISTRATION;

EID: 70350584980     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0587     Document Type: Review

References (25)

1. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 1993; 329: 977-986
2. Welschen LM, Bloemendal E, Nijpels G et al.: Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510-1517 (Pubitemid 40756728)
3. American Diabetes Association Consensus Statement: Self-monitoring of blood glucose. American Diabetes Association. Diabetes Care 1994; 17: 81-86
4. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA: Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271-278 (Pubitemid 43185395)
5. IDF Clinical Guidelines Task Force: The role of glucose monitoring in diabetes. A valuable technology in appropriate settings. www.idf.org/home/index. cfm?printpage=1&node=1383 2005
6. McNally PG, Raymond NT, Burden ML, Burton PR, Botha JL, Swift PG, Burden AC, Hearnshaw JR: Trends in mortality of childhood-onset insulin-dependent diabetes mellitus in Leicestershire: 1940-1991. Diabet Med 1995; 12: 961-966
7. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G: Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006; 49: 298-305. (Pubitemid 43185398)
8. Schiffrin A, Belmonte M: Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982; 5: 479-484 (Pubitemid 12015085)
9. Harris MI: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001; 24: 979-982 (Pubitemid 33716362)
10. Yki-Järvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M: Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1999; 130: 389-396
11. Franciosi M, Pellegrini F, De Berardis G et al.: Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med 2005; 22: 900-906 (Pubitemid 40942589)
12. Holstein A, Egberts EH: Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes. Exp Clin Endocrinol Diabetes 2003; 111: 405-414 (Pubitemid 37486432)
13. Farmer A,Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A: Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 132. (Pubitemid 47172232)
14. Schwedes U, Siebolds M, Mertes G: Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin- treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928-1932 (Pubitemid 41071046)
15. Kleinwechter H, Bührer C, Hunger-Dathe W et al.: Diabetes und Schwangerschaft. In: Scherbaum WA, Kerner W (Hrsg.): Praxis- Leitlinien der Deutschen Diabetes-Gesellschaft (DDG). Diabetologie und Stoffwechsel, 2007: 211-217
16. United Kingdom Prospective Diabetes Study Group: U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995; 44: 1249-1258
17. Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005-2012
18. The Diabetes Control and Complications Trial Research Group: Hypoglycaemia in the diabetes control and complications trial. Diabetes 2007; 46: 271-286
19. United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853
20. Asplund K, Wiholm BE, Lithner F: Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983; 24: 412-417
21. Jovanovic L, Dailey G, 3rd, Huang WC, Strange P, Goldstein BJ: Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study. J Clin Pharmacol 2000; 40: 49-57.
22. Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S: Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care 2000; 23: 1660-1665 (Pubitemid 30812640)
23. Fritsche A, Schweitzer MA, Häring HU: Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial. Ann Intern Med 2003; 138: 952-959 (Pubitemid 38129115)
24. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS: Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 1995; 18: 1113-1123
25. Murata GH, Shah JH, Hoffman RM,Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC: Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003; 26: 1759-1763